[Samitin]

... получил [Ссылки доступны только зарегистрированным пользователям ]ФДА.

Lilly said in a press release: "Baqsimi is the first and only nasally administered glucagon, and it was designed with severe hypoglycemia rescue in mind. It is compact, portable and ready to use (no reconstitution required) in a single, fixed, 3 mg dose."